N-Acetyl Epitalon Amidate
NAEA · Ac-Epitalon-NH2 · acetylated amidated epitalon
N-acetylated, C-amidated AEDG (epitalon) — the same stability-cap trick as NASA on Semax. Dosage Peptide and others list a 5 mg longevity protocol. Dedicated analog papers are essentially absent. Parent epitalon/epithalamin literature (Khavinson) does not automatically transfer.
Mechanism of Action
NAEA is AEDG (epitalon) with an N-acetyl cap and C-terminal amide — the same exopeptidase-evasion trick as NASA on Semax. Parent epitalon/epithalamin literature is Khavinson pineal-tetrapeptide work (PMID 12937225). This analog does not have its own human PK paper.
Source: Parent epitalon PMID: 12937225. NAEA: no indexed human PK as of 2026.
Analog, not a second epitalon trial
Vendor 5 mg “longevity protocols” are not citations. If you need evidence, read epitalon and treat this as uncharacterized.
Dosing Protocol
| Typical Dose | 5-10 mg/day (vendor longevity protocols; analog-specific PK absent) |
| Frequency | 1× daily for 10-20 day cycles (vendor) |
| Half-Life | Unknown for this analog (parent epitalon PK is already thin) |
| Common Vial Sizes | 10 mg, 50 mg |
Dosing Protocols
Vendor longevity SKU
Body-Weight Dosing Reference
Estimated doses extrapolated from the published research range of 5000–10000 mcg/day (referenced to 70 kg / 154 lb). These are approximations — consult a qualified healthcare provider for personalised guidance.
| Weight | Low Dose | Target Dose | High Dose |
|---|---|---|---|
| 120 lb(54 kg) | 3857 mcg | 5786 mcg | 7714 mcg |
| 140 lb(63 kg) | 4500 mcg | 6750 mcg | 9000 mcg |
| 160 lb(73 kg) | 5214 mcg | 7821 mcg | 10429 mcg |
| 180 lb(82 kg) | 5857 mcg | 8786 mcg | 11714 mcg |
| 200 lb(91 kg) | 6500 mcg | 9750 mcg | 13000 mcg |
| 220 lb(100 kg) | 7143 mcg | 10714 mcg | 14286 mcg |
| 250 lb(113 kg) | 8071 mcg | 12107 mcg | 16143 mcg |
💉 For exact syringe units based on your vial concentration, use the N-Acetyl Epitalon Amidate Reconstitution Calculator →
Administration
Expected Timeline
Who Is It For?
Longevity analog SKU
LowHigh catalog presence, near-zero analog papers.
Reconstitution Example
Safety & Considerations
Research analog. Parent claims (telomerase, pineal) are already contested. Analog does not make them stronger. Not a drug.
Regulatory & Legal Status
Stability analog of epitalon. No analog-specific human PK or approval
Not currently on the WADA 2026 Prohibited List. Policies may change — verify before competition.
Research Chemical
US Compounding: Not eligible / not available
⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.
N-Acetyl Epitalon Amidate vs. Epitalon
| Attribute | N-Acetyl Epitalon Amidate | Epitalon |
|---|---|---|
| Structure | N-acetyl + C-amide AEDG | Parent AEDG tetrapeptide |
| Human PK | None for this analog | Thin even for the parent |
| SKU | NAEA / 5 mg vendor protocols | Standard epitalon vial |
Verdict: Same cap trick as NASA. Parent papers stay on epitalon. Analog claims are chemistry inference.
Dosing Quick Reference
Frequently Asked Questions
Is this stronger than epitalon?▼
Same as epithalamin?▼
References
- Khavinson V et al. “Epitalon parent literature.” Biogerontology / related (2003). PMID: 12937225
Looking for a trusted source? See our recommended suppliers →
Independently tested · COA-verified · Save 10% with our exclusive code